Camp4 Therapeutics Corp (CAMP): Cash & Equivalents
$109.52M
As of 2025-12-31
$86.40M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $109.52M | +71.0% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $64.04M | +66.9% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $38.38M | n/a | 2025-03-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.07M | -16.3% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $8.24M | -8.5% |
| TherapeuticsMD, Inc. (TXMD) | 2024-12-31 | $5.06M | +16.9% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $345.1K | -44.9% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $101.58M | -68.8% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $90.0K | -86.7% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $125.14M | -41.1% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.09M | -44.0% |
Compare CAMP, MRKR, CRVO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗